S&P 5007,785.76▼0.2% Nasdaq26,729.16▼0.3% Dow53,732.41▼0.2% Russell 2K3,068.42▲0.5% 10-Yr4.70%+6bp VIX14.25−0.38 WTI$82.40▲1.4% Gold$4,432.00▲1.6% EUR/USD1.157▲0.4% BTC$64,768▲0.4% Nikkei68,309▲1.2%
At close · Fri, Aug 14, 2026
Daily Market Updates.

US Markets

Home›US Markets›Sectors›Hims & Hers CEO challenges FTC case, citing GLP-1 and…

Hims & Hers CEO challenges FTC case, citing GLP-1 and AI claims

CNBC reports the CEO said the FTC’s lawsuit misunderstands how the company operates, including its GLP-1 and AI-related efforts.

Reported · Written up by our desk · Sectors

Hims & Hers CEO Andrew Dudum said the FTC’s lawsuit against the telehealth company misunderstands how it operates, according to CNBC Markets.

In an interview with CNBC, Dudum addressed the regulator’s allegations as they relate to the company’s efforts involving compounded GLP-1 drugs and the use of AI.

The company’s comments come as the FTC pursues legal action over its business practices, and Dudum argued the case does not reflect the way Hims & Hers works, CNBC reported.

← Newer storyMichael Burry buys March 2027 puts on Palantir, citing valuation

More like this

US MarketsAI chip stocks slip as expectations collide with higher Treasury yields
US MarketsNvidia pushes AI expansion with new compute financing and credit support
US MarketsNvidia leans on capital edge as AI chip competition intensifies
US MarketsStartup uses AI to guide rare disease families from genetic diagnosis to treatments
US MarketsBig Oil’s liabilities shrink as bond yields weigh on investors

Sources

CNBC MarketsHims & Hers CEO says FTC lawsuit misunderstands how the company works

Get the close, explained.

One email every trading day: what moved, why it moved, and what's on deck tomorrow. Read in 3 minutes.

Free. Unsubscribe anytime.